According to a new report from  Intel Market Research , the  global Respiratory Syncytial Virus Therapeutic Drugs market  was valued at  USD 1.75 billion in 2025  and is projected to reach  USD 3.48 billion by 2034 , growing at a  steady CAGR of 7.8%  during the forecast period (2026–2034). This growth trajectory is primarily fueled by rising...